US2006155234A1PendingUtilityA1
Hemostatic dressing
Est. expirySep 10, 2022(expired)· nominal 20-yr term from priority
A61F 13/00063A61L 15/32A61F 13/00991A61F 2013/00927A61P 7/04A61L 15/64A61L 2400/04A61F 2013/00106A61F 2013/00463A61K 38/4833A61L 15/225A61F 2013/0054A61F 2013/00472A61F 2013/0091A61F 13/01034A61F 13/01029
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a hemostatic dressing which comprises a plurality of layers that contain resorbable materials and/or coagulation proteins. In particular, the invention includes dressings in which a layer of thrombin is sandwiched between a first and second layer of fibrinogen and wherein the layer of thrombin is not coextensive with the first and/or second layer of fibrinogen. The hemostatic dressings are useful for the treatment of wounded tissue.
Claims
exact text as granted — not AI-modified1 . A hemostatic dressing which comprises:
(i) a first fibrinogen layer; (ii) a thrombin layer adjacent to said first fibrinogen layer; and (iii) a second fibrinogen layer adjacent to said thrombin layer, wherein the thrombin layer is noncoextensive with the first fibrinogen layer and/or the second fibrinogen layer.
2 . A hemostatic dressing which comprises:
(i) a resorbable material layer; (ii) a first fibrinogen layer adjacent to said resorbable material layer; (iii) a thrombin layer adjacent to said first fibrinogen layer; and (iv) a second fibrinogen layer adjacent to said thrombin layer, wherein the thrombin layer is noncoextensive with the first fibrinogen layer and/or the second fibrinogen layer.
3 . A hemostatic dressing which comprises:
(i) a first fibrinogen layer; (ii) a resorbable material layer adjacent to said first fibrinogen layer; (iii) a thrombin layer adjacent to said resorbable material layer; and (iv) a second fibrinogen layer adjacent to said thrombin layer, wherein the thrombin layer is noncoextensive with the first fibrinogen layer and/or the second fibrinogen layer.
4 . The hemostatic dressing according to any one of claims 1 - 3 , wherein the thrombin layer is coextensive with 5% to 95% of the first fibrinogen layer.
5 . The hemostatic dressing of claim 4 , wherein the thrombin layer is coextensive with 20 to 50% of the first fibrinogen layer.
6 . The hemostatic dressing according to any one of claims 1 - 3 , wherein the thrombin layer is coextensive with 5% to 95% of the second fibrinogen layer.
7 . The hemostatic dressing of claim 6 , wherein the thrombin layer is coextensive with 20 to 50% of the first fibrinogen layer.
8 . The hemostatic dressing according to any one of claims 1 - 3 , wherein the thrombin layer is configured as an array of spots comprising thrombin.
9 . The hemostatic dressing according to any one of claims 1 - 3 , wherein the thrombin layer is configured as a single spot comprising thrombin.
10 . The hemostatic dressing according to any one of claims 1 - 3 , wherein the thrombin layer is configured as a plurality of lines comprising thrombin.
11 . The hemostatic dressing according to any one of claims 1 - 3 , further comprising a backing material.
12 . The hemostatic dressing of claim 2 , wherein said resorbable material is selected from the group consisting of glycolic acid polymers, lactic acid polymers and glycolic acid/lactic acid co-polymers.
13 . The hemostatic dressing according to any one of claims 1 - 3 , wherein one or more of said layers comprises a solubilizing agent.
14 . The hemostatic dressing according to any one of claims 1 - 3 , wherein one or more of said layers comprises a filler.
15 . The hemostatic dressing according to any one of claims 1 - 3 , wherein one or more of said layers comprises a binding agent.
16 . A method of treating wounded tissue, which comprises applying to said wounded tissue a hemostatic dressing according to any one of claims 1 - 3 .
17 . The method of claim 16 , further comprises hydrating said hemostatic dressing with a liquid that is exogenous to the wounded tissue.
18 . The method of claim 16 , further comprising hydrating said hemostatic dressing with a liquid that is endogenous to the wounded tissue.
19 . A method for preparing a hemostatic dressing, the method comprising:
providing a first layer of fibrinogen; applying a layer of thrombin to said first layer of fibrinogen; and applying a second layer of fibrinogen to the layer of thrombin, wherein the layer of thrombin is noncoextensive with the first fibrinogen layer and/or the second fibrinogen layer.
20 . The method of claim 19 , wherein the thrombin layer is coextensive with 5% to 95% of the first fibrinogen layer.
21 . The method of claim 19 , wherein the thrombin layer is coextensive with 5% to 95% of the second fibrinogen layer.
22 . A method for preparing a hemostatic dressing, the method comprising:
providing a resorbable or nonresorbable backing layer having attached thereto a first layer of fibrinogen; applying a layer of thrombin to said first layer of fibrinogen on a side of the fibrinogen layer that is opposite of the side to which the resorbable or nonresorbable backing layer is attached; and applying a second layer of fibrinogen to the layer of thrombin, wherein the layer of thrombin is noncoextensive with the first fibrinogen layer and/or the second fibrinogen layer.
23 . The method of claim 22 , wherein the thrombin layer is coextensive with 5% to 95% of the first fibrinogen layer.
24 . The method of claim 22 , wherein the thrombin layer is coextensive with 5% to 95% of the second fibrinogen layer.Join the waitlist — get patent alerts
Track US2006155234A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.